Alkem Laboratories has appointed Bipin Loke as its Chief Information Security Officer (CISO), effective November 2, 2026. Bipin joins the pharmaceutical company from Tata Communications, bringing experience in enterprise cybersecurity, security operations and industrial security to his new leadership role.
The appointment comes as cybersecurity assumes greater importance across industries integrating digital platforms with business-critical operations. In pharmaceutical manufacturing, the security landscape extends beyond corporate networks to include production infrastructure, connected systems and digital processes supporting manufacturing and distribution.
Bridging Enterprise IT and Industrial Security
Bipin's experience covers the development and management of security capabilities, cybersecurity transformation and resilience across information technology (IT) and operational technology environments. This combination is particularly relevant to organisations where digital systems support both business functions and physical production processes.
Enterprise IT security typically focuses on protecting networks, applications, identities and sensitive information. OT security, meanwhile, must account for industrial systems whose availability and reliability can directly affect manufacturing operations. Bringing these disciplines together requires security controls that address cyber risks without compromising operational continuity.
His background in SOC management also brings experience in security monitoring, threat detection and incident responseโfunctions that help organisations improve visibility across their technology environments and coordinate responses to emerging threats.
Why Cybersecurity Matters for Pharmaceutical Operations
Alkem Laboratories operates across generics, speciality pharmaceuticals and other healthcare segments, with a presence in more than 40 countries. Its business encompasses product development, manufacturing and distribution, creating a diverse environment in which information security intersects with operational reliability and the protection of business-critical data.
The company's manufacturing disclosures reference the use of digital systems such as process automation, electronic logbooks and electronic batch cards. These applications demonstrate the growing role of connected technology in manufacturing workflows and operational documentation.
As such systems become more integrated, cybersecurity programmes must consider risks across both conventional IT infrastructure and industrial environments. Unauthorised access, system disruption and compromised digital processes can create challenges that extend beyond information technology into day-to-day operations.
For pharmaceutical organisations, this makes coordinated security governance, threat monitoring and operational resilience important elements of their broader digital strategy.
Bringing Security Strategy Closer to Business Operations
Bipin's appointment represents a new sectoral assignment following his tenure at Tata Communications. His experience across enterprise security services and industrial environments provides a background relevant to the varied requirements of pharmaceutical operations.
The role places cybersecurity leadership at the intersection of technology governance, information protection and manufacturing resilience. As organisations continue to digitise their operations, security leaders are increasingly expected to align technical safeguards with business continuity and operational requirements.
For Alkem Laboratories, the appointment brings an experienced cybersecurity professional into a business environment where protecting digital infrastructure and maintaining reliable operations are closely connected priorities.
๐๐ญ๐๐ฒ ๐ข๐ง๐๐จ๐ซ๐ฆ๐๐ ๐ฐ๐ข๐ญ๐ก ๐จ๐ฎ๐ซ ๐ฅ๐๐ญ๐๐ฌ๐ญ ๐ฎ๐ฉ๐๐๐ญ๐๐ฌ ๐๐ฒ ๐ฃ๐จ๐ข๐ง๐ข๐ง๐ ๐ญ๐ก๐ WhatsApp Channel now! ๐๐ฒ
๐ญ๐๐๐๐๐ ๐ถ๐๐ ๐บ๐๐๐๐๐ ๐ด๐๐ ๐๐ ๐ท๐๐๐๐ฌ ๐ Facebook, LinkedIn, Twitter, Instagram